USD 1.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 183.3 Thousand USD | 0.0% |
2023 | 183.3 Thousand USD | 0.0% |
2022 | 183.3 Thousand USD | 147.03% |
2021 | 74.2 Thousand USD | 85.51% |
2020 | 40 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 101.00 USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | 183.3 Thousand USD | 0.0% |
2024 Q1 | 183.3 Thousand USD | 0.0% |
2024 Q2 | 183.3 Thousand USD | 0.0% |
2024 Q3 | 183.3 Thousand USD | 0.0% |
2024 Q4 | 183.3 Thousand USD | 0.0% |
2023 Q2 | 183.3 Thousand USD | 0.0% |
2023 Q1 | 183.3 Thousand USD | 0.0% |
2023 Q4 | 183.3 Thousand USD | 0.0% |
2023 FY | 183.3 Thousand USD | 0.0% |
2023 Q3 | 183.3 Thousand USD | 0.0% |
2022 Q3 | 98.3 Thousand USD | 0.0% |
2022 Q2 | 98.3 Thousand USD | 12.5% |
2022 Q1 | 87.37 Thousand USD | 17.76% |
2022 FY | 183.3 Thousand USD | 147.03% |
2022 Q4 | 183.3 Thousand USD | 86.47% |
2021 Q2 | 65.2 Thousand USD | 63.02% |
2021 Q3 | 57.24 Thousand USD | -12.22% |
2021 Q4 | 74.2 Thousand USD | 29.63% |
2021 FY | 74.2 Thousand USD | 85.51% |
2021 Q1 | 40 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | 40 Thousand USD | 0.0% |
2020 Q4 | 40 Thousand USD | 14.29% |
2020 Q3 | 35 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 Q1 | 29.65 Thousand USD | 0.0% |
2015 Q3 | 40.64 Thousand USD | 0.0% |
2015 Q2 | 40.64 Thousand USD | 37.05% |
2014 Q2 | 101.00 USD | 0.0% |
2014 Q1 | 101.00 USD | 0.0% |
2014 Q4 | - USD | -100.0% |
2014 FY | - USD | -100.0% |
2014 Q3 | 101.00 USD | 0.0% |
2013 FY | 101.00 USD | 0.0% |
2013 Q4 | 101.00 USD | -36.88% |
2013 Q2 | 160.00 USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | 160.00 USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bright Green Corporation | 1.85 Million USD | 90.101% |
Clever Leaves Holdings Inc. | 2.08 Million USD | 91.217% |
Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 99.707% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 482.04 Thousand USD | 61.975% |
Instadose Pharma Corp. | - USD | -Infinity% |